Insulin Glargine U 300
Indication
Type 1 diabetes mellitus
Amber level 0
Brand:
Toujeo®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Insulin glargine 300 units/mL (Toujeo®) is recommended as an option in adults with type 1 diabetes mellitus (T1DM) only in accordance with the recommendations in NICE NG17 and in those who experience an unacceptable frequency and/or severity of nocturnal hypoglycaemia on attempting to achieve better glycaemic control during treatment with first-line long-acting insulin analogues; or as a once daily insulin therapy for patients who require assistance with administering injections.
NICE guideline NG17: Type 1 diabetes in adults: diagnosis and management
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for initiation in primary care in line with restrictions
Supporting documents: